Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan

Shuichi Mizuta, Tomotaka Ugai, Satoshi Nishiwaki, Noriko Doki, Takahiro Fukuda, Tetsuya Nishida, Yuta Katayama, Shuichi Ota, Yuta Hasegawa, Masatsugu Tanaka, Makoto Onizuka, Tatsuo Ichinohe, Koji Kawamura, Yoshiko Atsuta, Yasuyuki Arai

Blood (2024) 144 (Supplement 1): 3569.

https://doi.org/10.1182/blood-2024-201434

Published: 2024

Journal Articles

Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL : JALSG Ph+ALL TKI- SCT Study

Blood (2022) 140 (Supplement 1): 6030–6032.

https://doi.org/10.1182/blood-2022-165864

Published: 2022

Journal Articles

Phase I Study of Cord Blood Transplantation with Intra-Bone Marrow Injection of Mesenchymal Stem Cells

Tatsunori Goto, MD, Makoto Murata, MD PhD, Tetsuya Nishida, MD PhD, Seitaro Terakura, MD PhD, Sonoko Kamoshita, MD, Yuichi Ishikawa, MD PhD, Yoko Ushijima, MD PhD, Yoshiya Adachi, MD PhD, Katsuyoshi Kato, PhD, Akihiro Hirakawa, PhD, Satoshi Nishiwaki, MD PhD, Nobuhiro Nishio, MD PhD, Yoshiyuki Takahashi, MD PhD, Yoshihisa Kodera, MD, Tadashi Matsushita, Hitoshi Kiyoi, MD PhD

Blood (2019) 134 (Supplement_1): 2004.

https://doi.org/10.1182/blood-2019-122101

Published: 2019

Journal Articles

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Blood (2019) 134 (Supplement_1): 4589.

https://doi.org/10.1182/blood-2019-126012

Published: 2019

Journal Articles

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Blood (2019) 134 (Supplement_1): 743.

https://doi.org/10.1182/blood-2019-123382

Published: 2019

Journal Articles

Optimal Interval for Detection of Molecular Relapse after Stop of TKI in Ph+ ALL Calculating By MRD Kinetics

Koichi Miyamura, MD PhD, Satoshi Nishiwaki

Blood (2018) 132 (Supplement 1): 5291.

https://doi.org/10.1182/blood-2018-99-112293

Published: 2018

Journal Articles

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, Yasuhiko Harada, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura

Blood (2017) 129 (1): 126–128.

https://doi.org/10.1182/blood-2016-08-734947

Published: 2017

Journal Articles

Significance of Fecal Occult Blood Test Followed By Colonoscopy for Asymptomatic Dasatinib-Induced Hemorrhagic Colitis (CML1501 Study)

Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, MD, Yasuhiko Harada, MD, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura

Blood (2016) 128 (22): 1917.

https://doi.org/10.1182/blood.V128.22.1917.1917

Published: 2016

Journal Articles

Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL – positive acute lymphoblastic leukemia

Shuichi Mizuta, Keitaro Matsuo, Satoshi Nishiwaki, Kiyotoshi Imai, Heiwa Kanamori, Kazuteru Ohashi, Takahiro Fukuda, Yasushi Onishi, Koichi Miyamura, Satoshi Takahashi, Makoto Onizuka, Yoshiko Atsuta, Ritsuro Suzuki, Yasuo Morishima, Koji Kato, Hisashi Sakamaki, Junji Tanaka

Blood (2014) 123 (15): 2325–2332.

https://doi.org/10.1182/blood-2013-11-538728

Published: 2014

Journal Articles

Impact of Macrophage Activation on Delayed Engraftment Following Allogeneic Hematopoietic Stem Cell Transplantation: Mac Ratio, a New Predictive Index

Naomi Kawashima, MD, Satoshi Nishiwaki, MD, PhD, Seitaro Terakura, MD, PhD, Sonoko Kamoshita, MD, Kyoko Watakabe, MD, Emi Yokohata, MD, Daisuke Koyama, MD, Naoko Shimizu, MD, PhD, Shingo Kurahashi, MD, PhD, Yukiyasu Ozawa, MD, PhD, Masafumi Ito, MD, PhD, Koichi Miyamura, MD, PhD

Blood (2013) 122 (21): 4527.

https://doi.org/10.1182/blood.V122.21.4527.4527

Published: 2013

Journal Articles

Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50–70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Heiwa Kanamori, MD, Shinichi Kako, MD, Harumi Kato, MD, Satoshi Nishiwaki, MD, Tatsuo Furukawa, MD, Mari Saito, MS, Shuichi Taniguchi, MD, PhD, Hirohisa Nakamae, MD, PhD, Toshiaki Yujiri, MD, Tokiko Naganuma-Inoue, MD, Yasuo Morishima, MD, PhD, Ritsuro Suzuki, MD, PhD, Hisashi Sakamaki, MD, Junji Tanaka, MD

Blood (2011) 118 (21): 1935.

https://doi.org/10.1182/blood.V118.21.1935.1935

Published: 2011

Journal Articles

Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in complete remission

Satoshi Nishiwaki, Yoshihiro Inamoto, Masahiro Imamura, Hisashi Tsurumi, Kazuo Hatanaka, Keisei Kawa, Ritsuro Suzuki, Koichi Miyamura

Blood (2011) 117 (13): 3698–3699.

https://doi.org/10.1182/blood-2011-01-329003

Published: 2011

Journal Articles

Allogeneic stem cell transplantation for adult Philadelphia chromosome–negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission

Satoshi Nishiwaki, Yoshihiro Inamoto, Hisashi Sakamaki, Mineo Kurokawa, Hiroatsu Iida, Hiroyasu Ogawa, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Masanobu Kasai, Takehiko Mori, Koji Iwato, Takashi Yoshida, Makoto Onizuka, Keisei Kawa, Yasuo Morishima, Ritsuro Suzuki, Yoshiko Atsuta, Koichi Miyamura

Blood (2010) 116 (20): 4368–4375.

https://doi.org/10.1182/blood-2010-02-269571

Published: 2010

Journal Articles

Optimization of Fludarabine + Melphalan Conditioning for Marrow Transplantation From Unrelated Donors for Patients with Hematopoietic Malignancies: A Prospective Dose-Finding Trial Using Modified Continual Reassessment Method.

Seitaro Terakura, MD, PhD, Masashi Sawa, MD, PhD, Haruhiko Ohashi, MD, PhD, Tomonori Kato, MD, Satoshi Nishiwaki, MD, Nobuhiko Imahashi, MD, Makoto Murata, MD, PhD, Koichi Miyamura, MD, PhD, Yoshiko Atsuta, MD, PhD, Ritsuro Suzuki, MD, PhD, Tomoki Naoe, MD, PhD, Tatsuya Ito, MD, PhD, Yoshihisa Morishita, MD, PhD

Blood (2009) 114 (22): 2273.

https://doi.org/10.1182/blood.V114.22.2273.2273

Published: 2009

Journal Articles

Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease

Satoshi Nishiwaki, Seitaro Terakura, Masafumi Ito, Tatsunori Goto, Aika Seto, Keisuke Watanabe, Mayumi Yanagisawa, Nobuhiko Imahashi, Shokichi Tsukamoto, Makoto Shimba, Yukiyasu Ozawa, Koichi Miyamura

Blood (2009) 114 (14): 3113–3116.

https://doi.org/10.1182/blood-2009-03-209635

Published: 2009

Journal Articles

Macrophage Infiltration of Skin Lesions Correlates to Prognosis of Gvhd; A Clue to Refractory Gvhd

Satoshi Nishiwaki, MD, Seitaro Terakura, MD, PhD, Tatsunori Goto, MD, Aika Seto, MD, Keisuke Watanabe, MD, Nobuhiko Imahashi, MD, Shokichi Tsukamoto, MD, Makoto Shimba, MD, Yukiyasu Ozawa, MD, PhD, Koichi Miyamura, MD, PhD, Masafumi Ito, MD, PhD

Blood (2008) 112 (11): 1178.

https://doi.org/10.1182/blood.V112.11.1178.1178

Published: 2008

Journal Articles

Impact of Posttransplant Imatinib Administration on Philadelphia-Chromosome Positive Acute Lymphocytic Leukemia

Satoshi Nishiwaki, Koichi Miyamura, Hisashi Sakamaki, MD, PhD, Shinji Nakao, Hideo Harigae, M.D, Seitaro Terakura, MD, PhD, Yoshihisa Kodera

Blood (2008) 112 (11): 4416.

https://doi.org/10.1182/blood.V112.11.4416.4416

Published: 2008

Journal Articles

Corticosteroid Therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogeneous Leukemia and Myelodysplastic Syndrome Overt Leukemia.

Nobuhiko Imahashi, MD, Aika Seto, MD, Keisuke Watanabe, MD, Mayumi Yanagisawa, MD, Satoshi Nishiwaki, MD, Makoto Shinba, MD, Takahiko Yasuda, MD, Koichi Miyamura, MD, PHD, Yoshihisa Kodera, MD, PHD

Blood (2007) 110 (11): 1660.

https://doi.org/10.1182/blood.V110.11.1660.1660

Published: 2007

NARROW

To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan

Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL : JALSG Ph+ALL TKI- SCT Study

Phase I Study of Cord Blood Transplantation with Intra-Bone Marrow Injection of Mesenchymal Stem Cells

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Optimal Interval for Detection of Molecular Relapse after Stop of TKI in Ph+ ALL Calculating By MRD Kinetics

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Significance of Fecal Occult Blood Test Followed By Colonoscopy for Asymptomatic Dasatinib-Induced Hemorrhagic Colitis (CML1501 Study)

Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL – positive acute lymphoblastic leukemia

Impact of Macrophage Activation on Delayed Engraftment Following Allogeneic Hematopoietic Stem Cell Transplantation: Mac Ratio, a New Predictive Index

Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50–70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in complete remission

Allogeneic stem cell transplantation for adult Philadelphia chromosome–negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission

Optimization of Fludarabine + Melphalan Conditioning for Marrow Transplantation From Unrelated Donors for Patients with Hematopoietic Malignancies: A Prospective Dose-Finding Trial Using Modified Continual Reassessment Method.

Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease

Macrophage Infiltration of Skin Lesions Correlates to Prognosis of Gvhd; A Clue to Refractory Gvhd

Impact of Posttransplant Imatinib Administration on Philadelphia-Chromosome Positive Acute Lymphocytic Leukemia

Corticosteroid Therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogeneous Leukemia and Myelodysplastic Syndrome Overt Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only